Back to Agenda
Session 2 Track 3: Demonstrating Value and Impact
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Medical Affairs Lead
Mesoblast, United States
To create both value and impact, individuals or teams must focus on achieving results that deliver immediate benefits (value) while also driving long-term, transformative outcomes (impact). Striking a balance between delivering exceptional results now and shaping future success is key. By dedicating efforts to meaningful work that addresses current needs while aligning with long-term goals, committing to continuous growth, and fostering strong relationships, individuals can amplify their contributions and influence. In this session, we will explore how the value you provide today can lead to lasting impact.
Learning Objective : - Evaluate the existing methods for measuring value and impact within the Field Medical Affairs Team, considering both individual and team-level approaches
-
Discuss best practices for revolutionizing the measurement of value and impact of Field Medical Affairs Teams
-
Identify possibilities to advance the development of immediate and long-term goals to advance this profession– where should we focus in the future
Speaker(s)
Speaker
Robin Winter-Sperry, MD
Pfizer (former), United States
Field Medical Excellence, International / Oncology Lead
Speaker
Peg Crowley-Nowick, PhD, MBA
Lumanity, United States
President, Medical Affairs Consulting and Head of Medical Affairs
Speaker
Ann Clark, PharmD
Genentech, Inc., United States
Field Director, Ophthalmology Medical Science Liaisons
Have an account?